Autoimmunity and benefit from trastuzumab treatment in breast cancer: Results from the HERA phase III trial Meeting Abstract


Authors: Sonnenblick, A.; Bailey, A.; Uziely, B.; Untch, M.; Smith, I.; Gianni, L.; Baselga, J.; Jackisch, C.; Cameron, D.; Bell, R.; Zardavas, D.; Al-Sakaff, N.; Gelber, R.; Dowsett, M.; Leyland-jones, B.; Piccart, M.; de Azambuja, E.
Abstract Title: Autoimmunity and benefit from trastuzumab treatment in breast cancer: Results from the HERA phase III trial
Meeting Title: 43rd ESMO Congress (ESMO 2018)
Journal Title: Annals of Oncology
Volume: 29
Issue: Suppl. 8
Meeting Dates: 2018 Oct 19-23
Meeting Location: Munich, Germany
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2018-10-01
Start Page: mdy270.213
Language: English
ACCESSION: WOS:000459277300216
PROVIDER: wos
DOI: 10.1093/annonc/mdy270.213
Notes: Meeting Abstract: 218P -- Appears on page viii70 of the abstract book -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jose T Baselga
    484 Baselga
Related MSK Work